Haleon commits ₹2,000 cr to first India plant at Pithampur, live by 2029-30
GSK spinoff Haleon will deploy ~₹2,000 crore (£175M) on a 40-acre greenfield facility in Madhya Pradesh, creating 500 jobs to manufacture Sensodyne, Eno, Crocin and Centrum for India and Asia export markets, targeting 300M consumers across oral health, VMS and pain relief.
What happened
Haleon will invest ~₹2,000 crore in its first India manufacturing facility, a 40-acre greenfield site at Pithampur, Madhya Pradesh, operational by 2029-30,
Key facts
- ₹2000 crore
- £175 million
- 40 acres
- 500 jobs
- 30% women employees
- 300 million consumers
- operational by 2029-30
Why this matters
Pithampur anchors Haleon's India footprint and likely triggers a wave of contract manufacturing renegotiations, bolt-on VMS or oral-care tuck-ins, and partnership conversations with MP-based suppliers ahead of the 2029-30 commissioning.